| The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia JR Srigley, B Delahunt, JN Eble, L Egevad, JI Epstein, D Grignon, O Hes, ... The American journal of surgical pathology 37 (10), 1469-1489, 2013 | 1230 | 2013 |
| The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters B Delahunt, JC Cheville, G Martignoni, PA Humphrey, C Magi-Galluzzi, ... The American journal of surgical pathology 37 (10), 1490-1504, 2013 | 768 | 2013 |
| Promotion of bladder cancer development and progression by androgen receptor signals H Miyamoto, Z Yang, YT Chen, H Ishiguro, H Uemura, Y Kubota, ... Journal of the National Cancer Institute 99 (7), 558-568, 2007 | 438 | 2007 |
| Androgen deprivation therapy for prostate cancer: current status and future prospects H Miyamoto, EM Messing, C Chang The Prostate 61 (4), 332-353, 2004 | 424 | 2004 |
| From estrogen to androgen receptor: a new pathway for sex hormones in prostate S Yeh, H Miyamoto, H Shima, C Chang Proceedings of the National Academy of Sciences 95 (10), 5527-5532, 1998 | 332 | 1998 |
| Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells H Miyamoto, S Yeh, G Wilding, C Chang Proceedings of the National Academy of Sciences 95 (13), 7379-7384, 1998 | 275 | 1998 |
| Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder H Miyamoto, JL Yao, A Chaux, Y Zheng, I Hsu, K Izumi, C Chang, ... BJU international 109 (11), 1716-1726, 2012 | 225 | 2012 |
| Non‐invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system H Miyamoto, JS Miller, DA Fajardo, TK Lee, GJ Netto, JI Epstein Pathology international 60 (1), 1-8, 2010 | 214 | 2010 |
| Non‐invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system H Miyamoto, JS Miller, DA Fajardo, TK Lee, GJ Netto, JI Epstein Pathology international 60 (1), 1-8, 2010 | 214 | 2010 |
| Non‐invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system H Miyamoto, JS Miller, DA Fajardo, TK Lee, GJ Netto, JI Epstein Pathology international 60 (1), 1-8, 2010 | 211 | 2010 |
| Renal tumors: diagnostic and prognostic biomarkers PH Tan, L Cheng, N Rioux-Leclercq, MJ Merino, G Netto, VE Reuter, ... The American journal of surgical pathology 37 (10), 1518-1531, 2013 | 210 | 2013 |
| ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor Z Yang, YJ Chang, IC Yu, S Yeh, CC Wu, H Miyamoto, DE Merry, ... Nature medicine 13 (3), 348-353, 2007 | 204 | 2007 |
| Δ5-Androstenediol is a natural hormone with androgenic activity in human prostate cancer cells H Miyamoto, S Yeh, H Lardy, E Messing, C Chang Proceedings of the National Academy of Sciences 95 (19), 11083-11088, 1998 | 198 | 1998 |
| Telomerase activity in human bladder cancer. Y Lin, H Miyamoto, K Fujinami, H Uemura, M Hosaka, Y Iwasaki, Y Kubota Clinical cancer research: an official journal of the American Association …, 1996 | 185 | 1996 |
| Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells S Yeh, H Miyamoto, K Nishimura, H Kang, J Ludlow, P Hsiao, C Wang, ... Biochemical and biophysical research communications 248 (2), 361-367, 1998 | 181 | 1998 |
| The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer JI Epstein, MB Amin, SW Fine, F Algaba, M Aron, DE Baydar, AL Beltran, ... Archives of pathology & laboratory medicine 145 (4), 461-493, 2021 | 180 | 2021 |
| Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4–STAT3 signaling LY Fang, K Izumi, KP Lai, L Liang, L Li, H Miyamoto, WJ Lin, C Chang Cancer research 73 (18), 5633-5646, 2013 | 163 | 2013 |
| Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails AS Duffield, TK Lee, H Miyamoto, HB Carter, JI Epstein The Journal of urology 182 (5), 2274-2279, 2009 | 160 | 2009 |
| ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors S Yamashita, KP Lai, KL Chuang, D Xu, H Miyamoto, T Tochigi, ST Pang, ... Neoplasia 14 (1), 74-IN12, 2012 | 158 | 2012 |
| ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors S Yamashita, KP Lai, KL Chuang, D Xu, H Miyamoto, T Tochigi, ST Pang, ... Neoplasia 14 (1), 74-IN12, 2012 | 158 | 2012 |
